SlideShare a Scribd company logo
1 of 1
Bioinformatics
Identified VlsE1 as top hit for potential ganglioside-binding protein.
VlsE1 localizes to the outer membrane of the cell.
Known to be involved in late-stage Lyme disease [4].
Although crystal structure is available, its function is unknown.
VlsE1 is found on linear plasmid-28.
 Required for pathogenesis for Lyme disease [5].
Identified possible ganglioside-binding motif [6].
Sub-cloning and Expression
Commercially synthesized VlsE1.
Sub-cloned into pET-28 to give N-terminal Histidine tag.
Expression Studies
 Modified media and concentration of IPTG parameters to produce the
best yield of soluble VlsE1.
Purification
 Trial purification with His-Select resin.
Drew E. Phelan, Christopher W. Reid
REFERENCES
1 Eicken, C., & Sharma, V. (2002). Crystal Structure of Lyme Disease Variable
Surface Antigen VlsE of Borrelia burgdorferi. V. Biol Chem. 277.
2 Garcia- Monco, J.C., Seidman, R.J., Benach, J.L., (1995). Experimental
immunization with Borrelia burgdorferi induces development of
antibodies to gangliosides. Infect Immun 63, 4130-4137.
3 Girschick, H., Morbach, H., Tappe, D. (2009). Treatment of Lyme borreliosis.
Arthritis Research and Therapy.
4 Polypeptides and Methods for the Specific Detection of Antibodies in
Patients with a Borrelia Infection. USSN 8,431,135 B2.
5 Lawrenz, M., Wooten, R., Norris, S. (2004). Effects of vlsE
Complementation on Infectivity of Borrelia burgdorferi Lacking the
Linear Plasmid lp28. Infect Immun.
6 Matsubara, T., Onishi, A., Sato, T. (2012). Carbohydrate Recognition by
Pentadecapeptide Ligands for a Series of Sialylated Oligosaccharides.
Bioorganic and Medicinal Chemistry Journal.
INTRODUCTION
The Center for Disease Control (CDC) estimates that there are
around 35,000 cases of Lyme disease (including unreported
cases) within the United States in recent years [1]. Lyme
disease is known to be caused by Borrelia burgdorferi, a
spirochete diderm without any LPS. Left undiagnosed, this
disease can run rampant throughout the body causing several
long-term neurological affects including myelitis and facial
nerve paralysis[1]. B. burgdorferi has been shown to bind to
gangliosides [2]. However the B. burgdorferi proteins
responsible have yet to be identified. The host-pathogen of the
Borellia infection process interaction has only been understood
in part. While B. burgdorferi is highly treatable with antibiotics,
if left undiagnosed, some can develop chronic persistent Lyme
disease [3]. Our research goal was to identify possible
ganglioside-binding proteins that are found within Borrelia
burgdorferi sensu lato.
MATERIALS & METHODS
RESULTS DISCUSSION
Bioinformatics
Identified top hit utilizing BLAST-p algorithm and narrowed
results down to one hit as shown in Table 1.
Literature mining showed that VlsE1 was shown to be
involved in late-stage Lyme disease.
Found possible ganglioside-binding motif within amino
acid sequence of VlsE1.
Sub-cloning and Expression
Cloned VlsE1 into pET-28.
Successfully expressed VlsE1 into BL21(DE3) pLlysS
expression strain.
Began concentration trials and identified .10 mM IPTG to be
slightly more optimal as shown in Figure 4.
Explored growth media for optimal protein expression
(utilized 2xYT, Super Broth, Terrific Broth and Luria Broth).
Began first purification attempt.
As shown in Panel C, VlsE1 remained insoluble.
Department of Science and Technology, Bryant University
1150 Douglas Turnpike, Smithfield RI 02917
Shiga Toxin
Figure 1: Flow chart of bioinformatics analysis.
Figure 2: Flow chart of sub-cloning and expression work of
VlsE1.
FUTURE WORK
• Continue to optimize expression and purification.
• Continue to optimize different conditions (including growth
media, IPTG concentration and incubation temperatures).
• Initiate a GST-fusion protein purification trial.
• Initiate experiments in order to identify the function of VlsE1.
• Screen VlsE1 for capacity to bind gangliosides utilizing
immuno- thin layer chromatography.
• Biochemically quantify the protein- ganglioside interaction of
VlsE1 utilizing hydrogen/ deuterium exchange MALDI MS (4,5).VlsE1
A
Table 1: Results of Bioinformatics methods.
B
289- R G M A K D G KF AV -299
GT1-b Motif- R X X A (F/W) X X S X ● (V/L)
C
Blast into sensu lato strain
1 2 3 4 5 6
1 2 3 4 5 6 7 8 9 10
D
ACKNOWLEDGEMENTS
Special thanks to Rhode Island INBRE SURF program for funding.
The Reid Research Group and The Glycomics Lab at Bryant University.
Special appreciation to Bryant University Academic Affairs for their support.
1 2 3 4 5 6 7 8 9 10
Bait
Protein
Borrelia
Match GI
Proposed
Name
Query
Cover
E- Value Identity
Effector
Results
PSORT
Results
Literature
Mining-
Found in
late stage
Lyme?
β-amyloid 503789484 Hypothetical
Protein
50% 2.7 52% None Cytoplasm No
β-amyloid 490932207 LysM
domain/M23
71% 3.1 38% None Cytoplasm No
β-amyloid 657248935 Peptidase
M23
71% 4.3 38% None Cytoplasm No
Shiga
Toxin
488739783 HD domain
Protein
35% .41 33% None Periplasmi
cmembran
e
No
Shiga
Toxin
501805000 Hypothetical
protein
84% 1.5 23% None Periplasmi
cmembran
e
No
Shiga
Toxin
3068754 Lipoprotein
OspE variant
84% 1.6 23% None Periplasmi
cmembran
e
No
Shiga
Toxin
186974253 VlsE1 29% 2.3 42% Sec
secreted
Bacterial
membrane
Yes
Panel A: Tertiary Structures shown above for both the bait protein, Shiga Toxin Subunit B
(1DM0), and the target protein, VlsE1 (1L8W).
Panel B: Coomassie SDS-Page Protein Gel of varying concentrations of IPTG added to
VlsE1. Lanes: 1) protein marker, 2) 0mM IPTG, 3) 0.1mM IPTG 4) 0.25mM IPTG, 5) 0.5mM
IPTG, 6) 1.0mM IPTG.
Panel C: Coomassie SDS-Page Protein Gel of expression study utilizing different growth
media. (1mM IPTG) Lanes: 1)protein marker 2) 2xYT Broth after Sonicated 3)Super Broth
after Sonicated 4) Terrific Broth after Sonicated 5) 2xYT Broth Lysate 6) Super Broth Lysate
7) Terrific Broth Lysate 8)2xYT Broth Centrifuge Pellet 9) Super Broth Centrifuge Pellet 10)
Terrific Broth Centrifuge Pellet
Panel D: Western Blot of growth media trials. Lanes: See Panel C.
Figure 4:
Figure 4: Amino Acid sequence fragment from VlsE1 with the ganglioside GT1-b motif below
highlighting exact matches in blue and conserved matches in green. (GT1-b is known to bind to
Borrelia burgdorferi.[2])

More Related Content

What's hot

Developing DNA topoisomerases as targets for antibacterial chemotherapy
Developing DNA topoisomerases as targets for antibacterial chemotherapyDeveloping DNA topoisomerases as targets for antibacterial chemotherapy
Developing DNA topoisomerases as targets for antibacterial chemotherapywarwick_amr
 
Studying DNA repair in Drosophila using attP site
Studying DNA repair in Drosophila using attP siteStudying DNA repair in Drosophila using attP site
Studying DNA repair in Drosophila using attP siteDavid Grossfeld
 
IPK 2014 poster v1_high resolution
IPK 2014 poster v1_high resolutionIPK 2014 poster v1_high resolution
IPK 2014 poster v1_high resolutionSam Fess, MSc
 
KDM5 epigenetic modifiers as a focus for drug discovery
KDM5 epigenetic modifiers as a focus for drug discoveryKDM5 epigenetic modifiers as a focus for drug discovery
KDM5 epigenetic modifiers as a focus for drug discoveryChristopher Wynder
 
The role of integrase inhibitors in first line and later antiretroviral thera...
The role of integrase inhibitors in first line and later antiretroviral thera...The role of integrase inhibitors in first line and later antiretroviral thera...
The role of integrase inhibitors in first line and later antiretroviral thera...Hivlife Info
 
the discovery of Raltegravir
the discovery of Raltegravirthe discovery of Raltegravir
the discovery of RaltegravirAllen Che
 
Ldb 145 Geni Mutanti_2014-11-19 Jamora - mercato biomedico 6
Ldb 145 Geni Mutanti_2014-11-19 Jamora - mercato biomedico 6Ldb 145 Geni Mutanti_2014-11-19 Jamora - mercato biomedico 6
Ldb 145 Geni Mutanti_2014-11-19 Jamora - mercato biomedico 6laboratoridalbasso
 
Epigenetics and small molecule
Epigenetics and small moleculeEpigenetics and small molecule
Epigenetics and small moleculeFei Xiang
 
Ld b 145 geni mutanti_2014-11-18 jamora - ricerca scientifica 3
Ld b 145 geni mutanti_2014-11-18 jamora - ricerca scientifica 3Ld b 145 geni mutanti_2014-11-18 jamora - ricerca scientifica 3
Ld b 145 geni mutanti_2014-11-18 jamora - ricerca scientifica 3laboratoridalbasso
 
Ecology Practicals2
Ecology Practicals2Ecology Practicals2
Ecology Practicals2medik.cz
 
Ldb 145 Geni Mutanti_2014-11-19 Jamora - dalla ricerca al prodotto 5
Ldb 145 Geni Mutanti_2014-11-19 Jamora - dalla ricerca al prodotto 5Ldb 145 Geni Mutanti_2014-11-19 Jamora - dalla ricerca al prodotto 5
Ldb 145 Geni Mutanti_2014-11-19 Jamora - dalla ricerca al prodotto 5laboratoridalbasso
 
ZP Summer 2015 Poster
ZP Summer 2015 PosterZP Summer 2015 Poster
ZP Summer 2015 PosterZaw Phyo
 
Ashwini presentation
Ashwini presentationAshwini presentation
Ashwini presentationAshwani Patil
 
Plant epigenetic memory in plant growth behavior and stress response. Sally M...
Plant epigenetic memory in plant growth behavior and stress response. Sally M...Plant epigenetic memory in plant growth behavior and stress response. Sally M...
Plant epigenetic memory in plant growth behavior and stress response. Sally M...CIAT
 

What's hot (18)

Developing DNA topoisomerases as targets for antibacterial chemotherapy
Developing DNA topoisomerases as targets for antibacterial chemotherapyDeveloping DNA topoisomerases as targets for antibacterial chemotherapy
Developing DNA topoisomerases as targets for antibacterial chemotherapy
 
PD Presentation
PD PresentationPD Presentation
PD Presentation
 
Studying DNA repair in Drosophila using attP site
Studying DNA repair in Drosophila using attP siteStudying DNA repair in Drosophila using attP site
Studying DNA repair in Drosophila using attP site
 
IPK 2014 poster v1_high resolution
IPK 2014 poster v1_high resolutionIPK 2014 poster v1_high resolution
IPK 2014 poster v1_high resolution
 
KDM5 epigenetic modifiers as a focus for drug discovery
KDM5 epigenetic modifiers as a focus for drug discoveryKDM5 epigenetic modifiers as a focus for drug discovery
KDM5 epigenetic modifiers as a focus for drug discovery
 
The role of integrase inhibitors in first line and later antiretroviral thera...
The role of integrase inhibitors in first line and later antiretroviral thera...The role of integrase inhibitors in first line and later antiretroviral thera...
The role of integrase inhibitors in first line and later antiretroviral thera...
 
the discovery of Raltegravir
the discovery of Raltegravirthe discovery of Raltegravir
the discovery of Raltegravir
 
Ldb 145 Geni Mutanti_2014-11-19 Jamora - mercato biomedico 6
Ldb 145 Geni Mutanti_2014-11-19 Jamora - mercato biomedico 6Ldb 145 Geni Mutanti_2014-11-19 Jamora - mercato biomedico 6
Ldb 145 Geni Mutanti_2014-11-19 Jamora - mercato biomedico 6
 
Epigenetics and small molecule
Epigenetics and small moleculeEpigenetics and small molecule
Epigenetics and small molecule
 
Ld b 145 geni mutanti_2014-11-18 jamora - ricerca scientifica 3
Ld b 145 geni mutanti_2014-11-18 jamora - ricerca scientifica 3Ld b 145 geni mutanti_2014-11-18 jamora - ricerca scientifica 3
Ld b 145 geni mutanti_2014-11-18 jamora - ricerca scientifica 3
 
Ecology Practicals2
Ecology Practicals2Ecology Practicals2
Ecology Practicals2
 
Ldb 145 Geni Mutanti_2014-11-19 Jamora - dalla ricerca al prodotto 5
Ldb 145 Geni Mutanti_2014-11-19 Jamora - dalla ricerca al prodotto 5Ldb 145 Geni Mutanti_2014-11-19 Jamora - dalla ricerca al prodotto 5
Ldb 145 Geni Mutanti_2014-11-19 Jamora - dalla ricerca al prodotto 5
 
Nitub workshop july 2018
Nitub workshop july 2018Nitub workshop july 2018
Nitub workshop july 2018
 
ZP Summer 2015 Poster
ZP Summer 2015 PosterZP Summer 2015 Poster
ZP Summer 2015 Poster
 
Ashwini presentation
Ashwini presentationAshwini presentation
Ashwini presentation
 
Genotoxicity studies
Genotoxicity studiesGenotoxicity studies
Genotoxicity studies
 
Nc3R\'s Meeting
Nc3R\'s MeetingNc3R\'s Meeting
Nc3R\'s Meeting
 
Plant epigenetic memory in plant growth behavior and stress response. Sally M...
Plant epigenetic memory in plant growth behavior and stress response. Sally M...Plant epigenetic memory in plant growth behavior and stress response. Sally M...
Plant epigenetic memory in plant growth behavior and stress response. Sally M...
 

Similar to SURF poster

Assay Virtual Screening Compounds for the Inhibitory Potencies against BACE 1
Assay Virtual Screening Compounds for the Inhibitory Potencies against BACE 1Assay Virtual Screening Compounds for the Inhibitory Potencies against BACE 1
Assay Virtual Screening Compounds for the Inhibitory Potencies against BACE 1Ben Leong
 
Buck anti aggregation opportunity feb2013 eng
Buck anti aggregation opportunity feb2013 engBuck anti aggregation opportunity feb2013 eng
Buck anti aggregation opportunity feb2013 engEgor Sulkin
 
American Academy Of Dermatology Poster 2011
American  Academy Of  Dermatology  Poster 2011American  Academy Of  Dermatology  Poster 2011
American Academy Of Dermatology Poster 2011Judy Lawson
 
Eradicating diseases (genome)
Eradicating diseases (genome)Eradicating diseases (genome)
Eradicating diseases (genome)Utkarsh Verma
 
western blot upd.pptx
western blot upd.pptxwestern blot upd.pptx
western blot upd.pptxALDILATAMAHS
 
Cloning and Expression of recombinant Protein
Cloning and Expression of recombinant ProteinCloning and Expression of recombinant Protein
Cloning and Expression of recombinant ProteinGaurav Dwivedi
 
Mycotoxins dallas-filidei
Mycotoxins dallas-filideiMycotoxins dallas-filidei
Mycotoxins dallas-filideiHeidi Barrier
 
In vitro experiments of prokaryotic and eukaryotic antimicrobial peptide cyto...
In vitro experiments of prokaryotic and eukaryotic antimicrobial peptide cyto...In vitro experiments of prokaryotic and eukaryotic antimicrobial peptide cyto...
In vitro experiments of prokaryotic and eukaryotic antimicrobial peptide cyto...AI Publications
 
Antihypertensive Peptides; Synthesis, Properties and Application in Foods
Antihypertensive Peptides; Synthesis, Properties and Application in FoodsAntihypertensive Peptides; Synthesis, Properties and Application in Foods
Antihypertensive Peptides; Synthesis, Properties and Application in FoodsAkshay Ramani
 
001 Case Study - Submission Point_c1051231_attempt_2023-11-23-14-08-42_ABS CW...
001 Case Study - Submission Point_c1051231_attempt_2023-11-23-14-08-42_ABS CW...001 Case Study - Submission Point_c1051231_attempt_2023-11-23-14-08-42_ABS CW...
001 Case Study - Submission Point_c1051231_attempt_2023-11-23-14-08-42_ABS CW...marwaahmad357
 
PROTAC Technology A New Application In Influenza Vaccines.pdf
PROTAC Technology A New Application In Influenza Vaccines.pdfPROTAC Technology A New Application In Influenza Vaccines.pdf
PROTAC Technology A New Application In Influenza Vaccines.pdfDoriaFang
 
Molecular pathogenesis
Molecular pathogenesisMolecular pathogenesis
Molecular pathogenesisMicrobiology
 
Molecular pathogenesis
Molecular pathogenesisMolecular pathogenesis
Molecular pathogenesisMicrobiology
 
Seminario/ BIOLOGIA MOLECULAR/ Majo Perez
Seminario/ BIOLOGIA MOLECULAR/ Majo Perez Seminario/ BIOLOGIA MOLECULAR/ Majo Perez
Seminario/ BIOLOGIA MOLECULAR/ Majo Perez MariaJosePerezZabala
 
Effect of molecules secreted by la 5
Effect of molecules secreted by la 5Effect of molecules secreted by la 5
Effect of molecules secreted by la 5Thảo Phạm
 

Similar to SURF poster (20)

Antigens and toxins
Antigens and toxinsAntigens and toxins
Antigens and toxins
 
Assay Virtual Screening Compounds for the Inhibitory Potencies against BACE 1
Assay Virtual Screening Compounds for the Inhibitory Potencies against BACE 1Assay Virtual Screening Compounds for the Inhibitory Potencies against BACE 1
Assay Virtual Screening Compounds for the Inhibitory Potencies against BACE 1
 
Buck anti aggregation opportunity feb2013 eng
Buck anti aggregation opportunity feb2013 engBuck anti aggregation opportunity feb2013 eng
Buck anti aggregation opportunity feb2013 eng
 
American Academy Of Dermatology Poster 2011
American  Academy Of  Dermatology  Poster 2011American  Academy Of  Dermatology  Poster 2011
American Academy Of Dermatology Poster 2011
 
Cloning_Expression_Purification_Vibrio_Lectin_Litopenaeus_Bacterial Agglutina...
Cloning_Expression_Purification_Vibrio_Lectin_Litopenaeus_Bacterial Agglutina...Cloning_Expression_Purification_Vibrio_Lectin_Litopenaeus_Bacterial Agglutina...
Cloning_Expression_Purification_Vibrio_Lectin_Litopenaeus_Bacterial Agglutina...
 
Eradicating diseases (genome)
Eradicating diseases (genome)Eradicating diseases (genome)
Eradicating diseases (genome)
 
western blot upd.pptx
western blot upd.pptxwestern blot upd.pptx
western blot upd.pptx
 
Cloning and Expression of recombinant Protein
Cloning and Expression of recombinant ProteinCloning and Expression of recombinant Protein
Cloning and Expression of recombinant Protein
 
Mycotoxins dallas-filidei
Mycotoxins dallas-filideiMycotoxins dallas-filidei
Mycotoxins dallas-filidei
 
Dr. Mark Filidei
Dr. Mark FilideiDr. Mark Filidei
Dr. Mark Filidei
 
Gfba Gene Essay
Gfba Gene EssayGfba Gene Essay
Gfba Gene Essay
 
In vitro experiments of prokaryotic and eukaryotic antimicrobial peptide cyto...
In vitro experiments of prokaryotic and eukaryotic antimicrobial peptide cyto...In vitro experiments of prokaryotic and eukaryotic antimicrobial peptide cyto...
In vitro experiments of prokaryotic and eukaryotic antimicrobial peptide cyto...
 
Antihypertensive Peptides; Synthesis, Properties and Application in Foods
Antihypertensive Peptides; Synthesis, Properties and Application in FoodsAntihypertensive Peptides; Synthesis, Properties and Application in Foods
Antihypertensive Peptides; Synthesis, Properties and Application in Foods
 
001 Case Study - Submission Point_c1051231_attempt_2023-11-23-14-08-42_ABS CW...
001 Case Study - Submission Point_c1051231_attempt_2023-11-23-14-08-42_ABS CW...001 Case Study - Submission Point_c1051231_attempt_2023-11-23-14-08-42_ABS CW...
001 Case Study - Submission Point_c1051231_attempt_2023-11-23-14-08-42_ABS CW...
 
PROTAC Technology A New Application In Influenza Vaccines.pdf
PROTAC Technology A New Application In Influenza Vaccines.pdfPROTAC Technology A New Application In Influenza Vaccines.pdf
PROTAC Technology A New Application In Influenza Vaccines.pdf
 
Molecular pathogenesis
Molecular pathogenesisMolecular pathogenesis
Molecular pathogenesis
 
FliC_delta_220_320_Salmonella_enteritidis_Adjuvant_Vaccine_Development.pdf
FliC_delta_220_320_Salmonella_enteritidis_Adjuvant_Vaccine_Development.pdfFliC_delta_220_320_Salmonella_enteritidis_Adjuvant_Vaccine_Development.pdf
FliC_delta_220_320_Salmonella_enteritidis_Adjuvant_Vaccine_Development.pdf
 
Molecular pathogenesis
Molecular pathogenesisMolecular pathogenesis
Molecular pathogenesis
 
Seminario/ BIOLOGIA MOLECULAR/ Majo Perez
Seminario/ BIOLOGIA MOLECULAR/ Majo Perez Seminario/ BIOLOGIA MOLECULAR/ Majo Perez
Seminario/ BIOLOGIA MOLECULAR/ Majo Perez
 
Effect of molecules secreted by la 5
Effect of molecules secreted by la 5Effect of molecules secreted by la 5
Effect of molecules secreted by la 5
 

SURF poster

  • 1. Bioinformatics Identified VlsE1 as top hit for potential ganglioside-binding protein. VlsE1 localizes to the outer membrane of the cell. Known to be involved in late-stage Lyme disease [4]. Although crystal structure is available, its function is unknown. VlsE1 is found on linear plasmid-28.  Required for pathogenesis for Lyme disease [5]. Identified possible ganglioside-binding motif [6]. Sub-cloning and Expression Commercially synthesized VlsE1. Sub-cloned into pET-28 to give N-terminal Histidine tag. Expression Studies  Modified media and concentration of IPTG parameters to produce the best yield of soluble VlsE1. Purification  Trial purification with His-Select resin. Drew E. Phelan, Christopher W. Reid REFERENCES 1 Eicken, C., & Sharma, V. (2002). Crystal Structure of Lyme Disease Variable Surface Antigen VlsE of Borrelia burgdorferi. V. Biol Chem. 277. 2 Garcia- Monco, J.C., Seidman, R.J., Benach, J.L., (1995). Experimental immunization with Borrelia burgdorferi induces development of antibodies to gangliosides. Infect Immun 63, 4130-4137. 3 Girschick, H., Morbach, H., Tappe, D. (2009). Treatment of Lyme borreliosis. Arthritis Research and Therapy. 4 Polypeptides and Methods for the Specific Detection of Antibodies in Patients with a Borrelia Infection. USSN 8,431,135 B2. 5 Lawrenz, M., Wooten, R., Norris, S. (2004). Effects of vlsE Complementation on Infectivity of Borrelia burgdorferi Lacking the Linear Plasmid lp28. Infect Immun. 6 Matsubara, T., Onishi, A., Sato, T. (2012). Carbohydrate Recognition by Pentadecapeptide Ligands for a Series of Sialylated Oligosaccharides. Bioorganic and Medicinal Chemistry Journal. INTRODUCTION The Center for Disease Control (CDC) estimates that there are around 35,000 cases of Lyme disease (including unreported cases) within the United States in recent years [1]. Lyme disease is known to be caused by Borrelia burgdorferi, a spirochete diderm without any LPS. Left undiagnosed, this disease can run rampant throughout the body causing several long-term neurological affects including myelitis and facial nerve paralysis[1]. B. burgdorferi has been shown to bind to gangliosides [2]. However the B. burgdorferi proteins responsible have yet to be identified. The host-pathogen of the Borellia infection process interaction has only been understood in part. While B. burgdorferi is highly treatable with antibiotics, if left undiagnosed, some can develop chronic persistent Lyme disease [3]. Our research goal was to identify possible ganglioside-binding proteins that are found within Borrelia burgdorferi sensu lato. MATERIALS & METHODS RESULTS DISCUSSION Bioinformatics Identified top hit utilizing BLAST-p algorithm and narrowed results down to one hit as shown in Table 1. Literature mining showed that VlsE1 was shown to be involved in late-stage Lyme disease. Found possible ganglioside-binding motif within amino acid sequence of VlsE1. Sub-cloning and Expression Cloned VlsE1 into pET-28. Successfully expressed VlsE1 into BL21(DE3) pLlysS expression strain. Began concentration trials and identified .10 mM IPTG to be slightly more optimal as shown in Figure 4. Explored growth media for optimal protein expression (utilized 2xYT, Super Broth, Terrific Broth and Luria Broth). Began first purification attempt. As shown in Panel C, VlsE1 remained insoluble. Department of Science and Technology, Bryant University 1150 Douglas Turnpike, Smithfield RI 02917 Shiga Toxin Figure 1: Flow chart of bioinformatics analysis. Figure 2: Flow chart of sub-cloning and expression work of VlsE1. FUTURE WORK • Continue to optimize expression and purification. • Continue to optimize different conditions (including growth media, IPTG concentration and incubation temperatures). • Initiate a GST-fusion protein purification trial. • Initiate experiments in order to identify the function of VlsE1. • Screen VlsE1 for capacity to bind gangliosides utilizing immuno- thin layer chromatography. • Biochemically quantify the protein- ganglioside interaction of VlsE1 utilizing hydrogen/ deuterium exchange MALDI MS (4,5).VlsE1 A Table 1: Results of Bioinformatics methods. B 289- R G M A K D G KF AV -299 GT1-b Motif- R X X A (F/W) X X S X ● (V/L) C Blast into sensu lato strain 1 2 3 4 5 6 1 2 3 4 5 6 7 8 9 10 D ACKNOWLEDGEMENTS Special thanks to Rhode Island INBRE SURF program for funding. The Reid Research Group and The Glycomics Lab at Bryant University. Special appreciation to Bryant University Academic Affairs for their support. 1 2 3 4 5 6 7 8 9 10 Bait Protein Borrelia Match GI Proposed Name Query Cover E- Value Identity Effector Results PSORT Results Literature Mining- Found in late stage Lyme? β-amyloid 503789484 Hypothetical Protein 50% 2.7 52% None Cytoplasm No β-amyloid 490932207 LysM domain/M23 71% 3.1 38% None Cytoplasm No β-amyloid 657248935 Peptidase M23 71% 4.3 38% None Cytoplasm No Shiga Toxin 488739783 HD domain Protein 35% .41 33% None Periplasmi cmembran e No Shiga Toxin 501805000 Hypothetical protein 84% 1.5 23% None Periplasmi cmembran e No Shiga Toxin 3068754 Lipoprotein OspE variant 84% 1.6 23% None Periplasmi cmembran e No Shiga Toxin 186974253 VlsE1 29% 2.3 42% Sec secreted Bacterial membrane Yes Panel A: Tertiary Structures shown above for both the bait protein, Shiga Toxin Subunit B (1DM0), and the target protein, VlsE1 (1L8W). Panel B: Coomassie SDS-Page Protein Gel of varying concentrations of IPTG added to VlsE1. Lanes: 1) protein marker, 2) 0mM IPTG, 3) 0.1mM IPTG 4) 0.25mM IPTG, 5) 0.5mM IPTG, 6) 1.0mM IPTG. Panel C: Coomassie SDS-Page Protein Gel of expression study utilizing different growth media. (1mM IPTG) Lanes: 1)protein marker 2) 2xYT Broth after Sonicated 3)Super Broth after Sonicated 4) Terrific Broth after Sonicated 5) 2xYT Broth Lysate 6) Super Broth Lysate 7) Terrific Broth Lysate 8)2xYT Broth Centrifuge Pellet 9) Super Broth Centrifuge Pellet 10) Terrific Broth Centrifuge Pellet Panel D: Western Blot of growth media trials. Lanes: See Panel C. Figure 4: Figure 4: Amino Acid sequence fragment from VlsE1 with the ganglioside GT1-b motif below highlighting exact matches in blue and conserved matches in green. (GT1-b is known to bind to Borrelia burgdorferi.[2])